.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Merck
Healthtrust
UBS
Mallinckrodt
Citi
QuintilesIMS
US Army
Argus Health
Medtronic

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050662

« Back to Dashboard
NDA 050662 describes BIAXIN, which is a drug marketed by Abbvie and is included in three NDAs. It is available from seven suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the BIAXIN profile page.

The generic ingredient in BIAXIN is clarithromycin. There are twenty-one drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.

Summary for NDA: 050662

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 050662

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BIAXIN
clarithromycin
TABLET;ORAL 050662 NDA AbbVie Inc. 0074-2586 0074-2586-60 60 TABLET, FILM COATED in 1 BOTTLE (0074-2586-60)
BIAXIN
clarithromycin
TABLET;ORAL 050662 NDA KAISER FOUNDATION HOSPITALS 0179-0021 0179-0021-88 720 TABLET in 1 BOTTLE (0179-0021-88)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Oct 31, 1991TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Oct 31, 1991TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
US Army
Cantor Fitzgerald
Argus Health
Novartis
Federal Trade Commission
Deloitte
Healthtrust
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot